Newsroom
March 10, 2022
The UT Health San Antonio Department of Cardiothoracic Surgery has earned a distinguished three-star rating from the Society of Thoracic Surgeons for its patient care and lung and esophageal cancer resection outcomes. The three-star rating denotes the highest category of quality and places the department among the elite for general thoracic surgery.
March 10, 2022
Only the most elite programs garner 3-star ratings from the Society of Thoracic Surgeons. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (March 10, 2022) — The UT Health San Antonio Department of Cardiothoracic Surgery has earned a distinguished three-star rating from the Society of Thoracic Surgeons (STS) for its patient care and lung and […]
March 4, 2022
UT Health San Antonio has appointed Laurence Morel, PhD, to chair the Department of Microbiology, Immunology and Molecular Genetics in the Joe R. and Teresa Lozano Long School of Medicine, effective June 13, 2022. Dr. Morel is a noted researcher of systemic lupus erythematosus (SLE). Laurence Morel, PhD Dr. Morel obtained her PhD from the […]
March 4, 2022
Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (March 4, 2022) — The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has appointed Laurence Morel, PhD, to chair the Department of Microbiology, Immunology and Molecular Genetics in the Joe R. and Teresa Lozano Long School of Medicine, effective June 13, 2022. […]
March 3, 2022
The FDA has approved pacritinib for myelofibrosis patients with low platelet counts. Investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, played a lead role in gaining U.S. Food and Drug Administration approval of pacritinib to treat the chronic leukemia known as myelofibrosis. The FDA granted accelerated approval of the […]
March 1, 2022
The FDA has approved pacritinib for myelofibrosis patients with low platelet counts. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Tuesday, March 1, 2022) — Investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, played a lead role in gaining U.S. Food and Drug Administration approval of pacritinib […]